Gilead Sciences Inc at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Gilead today. From the company, we're going to have a presentation from Dan O'Day, Chairman and CEO. And following the presentation, we'll jump into a Q&A session with Dan and the broader management team. So with that, Dan, Happy New Year. Thanks for joining us, and over to you.
' -
Thanks, Chris. Delighted to be here. Thank you for hosting us. Good morning, everybody. Delighted to have a chance to communicate with all of you this morning. I've got a great team up here, too, that can get into questions and answers with you as well. We're off to a really good start this year.
Let me just say that I think this is an incredibly important year for the company in 2024. I'll get into it. But the build that we've been doing over the past 4 years is really coming to fruition.
We more than doubled
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
